Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model
Cilostazol (CLZ) is an antiplatelet agent with limited solubility (∼ 6 μg/ml at 25° C), poor
absorption and low oral bioavailability. In this study, solid lipid nanoparticles (SLNs) were …
absorption and low oral bioavailability. In this study, solid lipid nanoparticles (SLNs) were …
Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model
M Bibi, Y Anwar, NA Alkenani… - JOURNAL OF …, 2022 - repository.hanyang.ac.kr
Cilostazol (CLZ) is an antiplatelet agent with limited solubility (similar to 6 mu g/ml at 25
degrees C), poor absorption and low oral bioavailability. In this study, solid lipid …
degrees C), poor absorption and low oral bioavailability. In this study, solid lipid …
[引用][C] Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model
M Bibi, Y Anwar, NA Alkenani, AT Zari… - JOURNAL OF …, 2022 - scholarworks.bwise.kr
Cilostazol (CLZ) is an antiplatelet agent with limited solubility (similar to 6 mu g/ml at 25
degrees C), poor absorption and low oral bioavailability. In this study, solid lipid …
degrees C), poor absorption and low oral bioavailability. In this study, solid lipid …